Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Stopped The study was "withdrawn" due to certain adverse events \[hypersensitivity\].

Conditions

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cavity Cancer

Interventions

• DRUG: carboplatin
• DRUG: decitabine

Sponsor

Cancer Research UK